Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine.

There are some corrections in the original article, Page 11, “/LYXUMIA” word has to be removed from the section RATIONALE FOR COMBINATION THERAPY COMP…

Read the full article here

Related Articles